The Senior Management Team (SMT) at Plasma Surgical comprises of professionals with extensive experience in healthcare and the medical device industry. The team’s expertise spans the entire range of activities including research and development, medical affairs, manufacturing, quality and regulatory, global product strategy, and sales and marketing.

Brian Tippett, MD, President and Chief Executive Officer
Dr. Tippett joined Plasma Surgical in 2014 as a leader on our Senior Management Medical Affairs Team. An engineer and physician by training, Dr. Tippett is a seasoned surgical device executive with experience spanning business development, clinical development, medical affairs, clinical training and marketing. Prior to joining Plasma Surgical and over the span of 15 years in the surgical device industry, he led successful product development and commercialization initiatives for several disruptive technologies at industry leaders including Allergan, Kinetic Concepts, and Intuitve Surgical.

Read More »

Dr. Tippett’s role onthe Plasma Surgical Executive Team changed in March 2016 when he accepted the position of President and Chief Executive Officer to lead the global reorganization of Plasma Surgical and its subsidiaries. Building on foundational technology, he is renewing corporate focus and resources toward the challenges of developing the next generation thermal plasma technology, expanding utilization globally, and improving the lives of patients through the advancement of surgical tools for complex open and laparoscopic procedures.


Dr. Tippett earned his Medical Degree from the University of Marlyand and completed internship and residency training in Baltimore, MD at Union Memorial Hospital and Johns Hopkins Hospital, respectively. In addition, he completed both undergraduate and graduate degrees in Mechanical Engineering with a specialization in soft tissue biomechanics prior to attending medical school.


 

Michael Emery, Vice President, Finance
Michael has broad financial management experience in the healthcare industry, including extensive familiarity with medical, regulatory and R&D related activities. He joined the company in June 2011 after spending 13 years at Solvay Pharmaceuticals in Atlanta.

Read More »

At Solvay, Michael worked as Controller of Finance and Accounting and managed the finance function through the acquisition of the company by Abbott Pharmaceuticals. Prior to joining Solvay, Michael worked as a Senior Financial Analyst with Prudential Health Care. He graduated with a B.S. cum laude in Accounting from Rutgers University.

Nikolay Suslov, Ph.D., EVP & Chief Technology Officer
Professor Nikolay Suslov graduated from the Moscow Bauman Technical Institute as its top ranking student and went on to complete his doctorate on the use of plasma engines on spacecraft. Nikolay continued his research in thermal and molecular physics at the Moscow Institute of Human Morphology, the Academy of Science and several leading Moscow hospitals. He gained his professorship in recognition for his work on the interaction between plasma energy sources and live biological tissues.

Read More »

During the 1990s, this research led to the development of the technology used in plasma surgery and to a series of patented inventions that are now used in the PlasmaJet system. He moved to Gothenburg, Sweden in 1998 and in 2000 co-founded Plasma Surgical.

Professor Nikolay Suslov is based in Atlanta and continues the development of plasma technology in his capacity as Executive Vice President and Chief Technology Officer.


 

Kerry Byler, Chief Financial Officer

Kerry brings to Plasma Surgical more than 15+ years of experience in Private Equity investing and portfolio company operations, having held multiple leadership roles in high growth and high potential Private Equity-backed Companies as CFO and COO.

Read More »

In Kerry’s most recent portfolio company Board assignment, he was the lead venture investor and mentor to a highly innovative, cloud-based Healthcare Services company that went from a “whiteboard” to Wall Street Journal Top Three Startup of The Year in less than 18 months.

Prior to moving into Portfolio Company operations, Kerry was Managing Director with BlueCross BlueShield Venture Partners (Chicago, IL), where he helped manage a corporate venturing initiative with over $300 million in committed capital across 17 portfolio companies and he was one of two Officers of the General Partner.

Kerry was originally trained in Institutional Venture Capital and Private Equity Investing and portfolio company operations by a two-time VentureOne U.S. Healthcare Investor of the Year while at The Sprout Group, the Private Equity affiliate of Donaldson, Lufkin & Jenrette/Credit Suisse First Boston. He received additional training in Private Equity Investing and portfolio company operations as part of the Senior Management Team at Batterson Venture Partners, whose Principals where the original lead Venture Investors in the Startup that eventually grew to become and subsequently changed its name to America Online, Inc. 

Kerry holds an M.B.A. in Strategic Management, Entrepreneurship and Analytic Finance from the University of Chicago Graduate School of Business and a B.S. in Finance with High Honors from the University of Tennessee.